Dynamics of the digestive acquisition of bacterial carriage and integron presence by French preterm newborns according to maternal colonization: The DAIR3N multicentric study.

Integrons antimicrobial resistance digestive acquisition gram-negative bacteria preterm newborn infant resistance markers

Journal

Frontiers in microbiology
ISSN: 1664-302X
Titre abrégé: Front Microbiol
Pays: Switzerland
ID NLM: 101548977

Informations de publication

Date de publication:
2023
Historique:
received: 19 01 2023
accepted: 21 02 2023
medline: 1 4 2023
entrez: 31 3 2023
pubmed: 1 4 2023
Statut: epublish

Résumé

The study aimed to describe the dynamics and risk factors of Gram-negative bacteria (GNB) acquisition in preterm infants. This prospective multicenter French study included mothers hospitalized for preterm delivery and their newborns, followed until hospital discharge. Maternal feces and vaginal fluids at delivery, and neonatal feces from birth to discharge were tested for cultivable GNB, potential acquired resistance, and integrons. The primary outcome was the acquisition of GNB and integrons in neonatal feces, and their dynamics, evaluated by survival analysis using the actuarial method. Risk factors were analyzed using Cox models. Two hundred thirty-eight evaluable preterm dyads were included by five different centers over 16 months. GNB were isolated in 32.6% of vaginal samples, with 15.4% of strains producing extended-spectrum beta-lactamase (ESBL) or hyperproducing cephalosporinase (HCase), and in 96.2% of maternal feces, with 7.8% ESBL-GNB or HCase-GNB. Integrons were detected in 40.2% of feces and 10.6% of GNB strains. The mean (SD) length of stay of newborns was 39.5 (15.9) days; 4 died in the hospital. At least one infection episode occurred in 36.1% of newborns. The acquisition of GNB and integrons was progressive from birth to discharge. At discharge, half of newborns had ESBL-GNB or HCase-GNB, independently favored by a premature rupture of membranes (Hazard Ratio (HR), 3.41, 95% confidence interval (CI), 1.71; 6.81), and 25.6% had integrons (protective factor: multiple gestation, HR, 0.367, 95% CI, 0.195; 0.693). In preterm newborns, the acquisitions of GNB, including resistant ones, and integrons are progressive from birth to discharge. A premature rupture of membranes favored the colonization by ESBL-GNB or Hcase-GNB.

Identifiants

pubmed: 36998410
doi: 10.3389/fmicb.2023.1148319
pmc: PMC10043237
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1148319

Informations de copyright

Copyright © 2023 Patry, Bothorel, Labrunie, Renesm, Lehours, Benard, Dubois, Ponthier, Meyer, Norbert, Villeneuve, Jouvencel, Leysenne, Chainier, Luce, Grélaud, Ploy, Bedu and Garnier.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Antimicrob Chemother. 2022 Feb 23;77(3):767-770
pubmed: 35195694
Clin Infect Dis. 2005 Jul 1;41(1):1-9
pubmed: 15937755
Res Microbiol. 2008 Apr;159(3):187-93
pubmed: 18281199
Pediatr Neonatol. 2018 Feb;59(1):35-41
pubmed: 28642139
Pediatr Neonatol. 2016 Aug;57(4):265-73
pubmed: 26750406
J Antimicrob Chemother. 2010 Aug;65(8):1642-5
pubmed: 20542899
JAMA Pediatr. 2015 Mar;169(3):230-8
pubmed: 25621457
Biometrics. 1986 Dec;42(4):845-54
pubmed: 3814726
Lancet Infect Dis. 2021 Dec;21(12):1677-1688
pubmed: 34384533
J Infect Dis. 2003 Jan 15;187(2):251-9
pubmed: 12552449
Bull World Health Organ. 2015 Jan 1;93(1):19-28
pubmed: 25558104
Int J Antimicrob Agents. 2014 Oct;44(4):351-3
pubmed: 25130099
J Antimicrob Chemother. 2021 Dec 24;77(1):213-217
pubmed: 34557914
Pediatr Obes. 2017 Aug;12 Suppl 1:3-17
pubmed: 28447406
Nat Microbiol. 2019 Jan;4(1):112-123
pubmed: 30478291
Pediatr Res. 2015 Jun;77(6):726-31
pubmed: 25760550
Front Microbiol. 2018 Jul 04;9:1467
pubmed: 30022973
J Antimicrob Chemother. 2019 Jun 1;74(6):1560-1562
pubmed: 30805633
Front Microbiol. 2017 Sep 27;8:1891
pubmed: 29021787
Annu Rev Genet. 2010;44:141-66
pubmed: 20707672
Microb Ecol. 2017 Nov;74(4):1001-1008
pubmed: 28492988
J Clin Microbiol. 2003 Nov;41(11):5224-6
pubmed: 14605168
Obstet Med. 2019 Sep;12(3):107-115
pubmed: 31523266
Antimicrob Agents Chemother. 2007 Jul;51(7):2366-72
pubmed: 17452479
Lancet. 2016 Jan 9;387(10014):168-75
pubmed: 26603918
Environ Microbiol. 2014 Sep;16(9):2891-904
pubmed: 24033881
Eur J Clin Microbiol Infect Dis. 2015 Feb;34(2):215-22
pubmed: 25213719
Sci Rep. 2015 Oct 28;5:15317
pubmed: 26507767
Drug Discov Today Technol. 2014 Mar;11:33-9
pubmed: 24847651

Auteurs

Alice Patry (A)

INSERM UMR, Limoges University, Limoges University Hospital, Limoges, France.

Philippe Bothorel (P)

Department of Pediatrics, Mother-Child Hospital, Limoges University Hospital, Limoges, France.

Anaïs Labrunie (A)

Epidemiology, Biostatistics, and Research Methodology Centre (CEBIMER), Limoges University Hospital, Limoges, France.

Laurent Renesme (L)

Department of Pediatrics, Neonatology and Maternity Unit, Pellegrin University Hospital, Bordeaux, France.

Philippe Lehours (P)

Bacteriology Laboratory, Pellegrin University Hospital, Bordeaux, France.

Melinda Benard (M)

Department of Pediatrics and Neonatology, CHU Toulouse, Toulouse, France.

Damien Dubois (D)

Bacteriology and Hygiene Department, Federative Institute of Biology, CHU Toulouse University Hospital, Toulouse, France.

Laure Ponthier (L)

Department of Pediatrics, Mother-Child Hospital, Limoges University Hospital, Limoges, France.

Sylvain Meyer (S)

INSERM UMR, Limoges University, Limoges University Hospital, Limoges, France.

Karine Norbert (K)

Department of Pediatrics, Pau Hospital, Pau, France.

Laurent Villeneuve (L)

Medical Biology Laboratory, Pau Hospital, Pau, France.

Philippe Jouvencel (P)

Department of Pediatrics and Neonatology, « Côte Basque » Hospital, Bayonne, France.

David Leysenne (D)

Microbiology Laboratory, « Côte Basque » Hospital, Bayonne, France.

Delphine Chainier (D)

INSERM UMR, Limoges University, Limoges University Hospital, Limoges, France.

Sandrine Luce (S)

Epidemiology, Biostatistics, and Research Methodology Centre (CEBIMER), Limoges University Hospital, Limoges, France.

Carole Grélaud (C)

INSERM UMR, Limoges University, Limoges University Hospital, Limoges, France.

Marie-Cecile Ploy (MC)

INSERM UMR, Limoges University, Limoges University Hospital, Limoges, France.

Antoine Bedu (A)

Department of Pediatrics, Mother-Child Hospital, Limoges University Hospital, Limoges, France.

Fabien Garnier (F)

INSERM UMR, Limoges University, Limoges University Hospital, Limoges, France.

Classifications MeSH